BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 15569047)

  • 1. Expression of enamel proteins and LEF1 in adamantinomatous craniopharyngioma: evidence for its odontogenic epithelial differentiation.
    Sekine S; Takata T; Shibata T; Mori M; Morishita Y; Noguchi M; Uchida T; Kanai Y; Hirohashi S
    Histopathology; 2004 Dec; 45(6):573-9. PubMed ID: 15569047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma.
    Kato K; Nakatani Y; Kanno H; Inayama Y; Ijiri R; Nagahara N; Miyake T; Tanaka M; Ito Y; Aida N; Tachibana K; Sekido K; Tanaka Y
    J Pathol; 2004 Jul; 203(3):814-21. PubMed ID: 15221941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region.
    Buslei R; Nolde M; Hofmann B; Meissner S; Eyupoglu IY; Siebzehnrübl F; Hahnen E; Kreutzer J; Fahlbusch R
    Acta Neuropathol; 2005 Jun; 109(6):589-97. PubMed ID: 15891929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of aberrant beta-catenin and impaired p63 in craniopharyngiomas.
    Cao J; Lin JP; Yang LX; Chen K; Huang ZS
    Br J Neurosurg; 2010 Jun; 24(3):249-56. PubMed ID: 20128632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear beta-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas.
    Buslei R; Hölsken A; Hofmann B; Kreutzer J; Siebzehnrubl F; Hans V; Oppel F; Buchfelder M; Fahlbusch R; Blümcke I
    Acta Neuropathol; 2007 May; 113(5):585-90. PubMed ID: 17221204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of amelogenin and cytokeratin 19 in epithelial odontogenic tumors.
    Kumamoto H; Yoshida M; Ooya K
    Oral Dis; 2001 May; 7(3):171-6. PubMed ID: 11495193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-Catenin is expressed aberrantly in tumors expressing shadow cells. Pilomatricoma, craniopharyngioma, and calcifying odontogenic cyst.
    Hassanein AM; Glanz SM; Kessler HP; Eskin TA; Liu C
    Am J Clin Pathol; 2003 Nov; 120(5):732-6. PubMed ID: 14608900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression patterns of hair and epithelial keratins and transcription factors HOXC13, LEF1, and beta-catenin in a malignant pilomatricoma: a histological and immunohistochemical study.
    Cribier B; Worret WI; Braun-Falco M; Peltre B; Langbein L; Schweizer J
    J Cutan Pathol; 2006 Jan; 33(1):1-9. PubMed ID: 16441405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-catenin/LEF1 activated enamelin expression in ameloblast-like cells.
    Tian H; Lv P; Ma K; Zhou C; Gao X
    Biochem Biophys Res Commun; 2010 Jul; 398(3):519-24. PubMed ID: 20599763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical detection of beta-catenin and adenomatous polyposis coli in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2005 Aug; 34(7):401-6. PubMed ID: 16011608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the calcification of adamantinomatous craniopharyngioma resemble the calcium deposition of osteogenesis/odontogenesis?
    Song-Tao Q; Xiao-Rong Y; Jun P; Yong-Jian D; Jin L; Guang-Long H; Yun-Tao L; Jian R; Xiang-Zhao L; Jia-Ming X
    Histopathology; 2014 Feb; 64(3):336-47. PubMed ID: 24387671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations.
    Sekine S; Shibata T; Kokubu A; Morishita Y; Noguchi M; Nakanishi Y; Sakamoto M; Hirohashi S
    Am J Pathol; 2002 Dec; 161(6):1997-2001. PubMed ID: 12466115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ghost cells in calcifying odontogenic cyst express enamel-related proteins.
    Takata T; Zhao M; Nikai H; Uchida T; Wang T
    Histochem J; 2000 Apr; 32(4):223-9. PubMed ID: 10872887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis.
    Jung HC; Kim K
    Life Sci; 2005 Jul; 77(11):1249-62. PubMed ID: 15979100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of bone morphogenetic proteins and their associated molecules in ameloblastomas and adenomatoid odontogenic tumors.
    Kumamoto H; Ooya K
    Oral Dis; 2006 Mar; 12(2):163-70. PubMed ID: 16476038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different keratin profiles in craniopharyngioma subtypes and ameloblastomas.
    Tateyama H; Tada T; Okabe M; Takahashi E; Eimoto T
    Pathol Res Pract; 2001; 197(11):735-42. PubMed ID: 11770017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Odontogenic classification of craniopharyngiomas: a clinicopathological study of 54 cases.
    Paulus W; Stöckel C; Krauss J; Sörensen N; Roggendorf W
    Histopathology; 1997 Feb; 30(2):172-6. PubMed ID: 9067743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-catenin/T-cell factor-mediated transcription is modulated by cell density in human bronchial epithelial cells.
    Steel MD; Puddicombe SM; Hamilton LM; Powell RM; Holloway JW; Holgate ST; Davies DE; Collins JE
    Int J Biochem Cell Biol; 2005 Jun; 37(6):1281-95. PubMed ID: 15778091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical detection and distribution of enamelysin (MMP-20) in human odontogenic tumors.
    Takata T; Zhao M; Uchida T; Wang T; Aoki T; Bartlett JD; Nikai H
    J Dent Res; 2000 Aug; 79(8):1608-13. PubMed ID: 11023283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative immunohistochemical expression of β-catenin, EGFR, ErbB2, and p63 in adamantinomatous and papillary craniopharyngiomas.
    Esheba GE; Hassan AA
    J Egypt Natl Canc Inst; 2015 Sep; 27(3):139-45. PubMed ID: 26198262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.